
Related articles


What is a forward deployed engineer, and why do today's clinical trials need one?
What exactly is a forward deployed engineer?
If you have spent any time around AI and enterprise software this year, you have probably heard the term FDE, or forward deployed engineer. It sounds like a buzzword, but the role is why we’re able to solve real problems for our clinical trial clients in record time.


The Agentic AI Use Cases Already Transforming Clinical Trials
Industry leaders share real-world insights on using agentic AI to streamline clinical trials, accelerate decisions, and improve study execution.


The future economics of CROs
The ground has shifted for FSO (functional service outsourcing) and Unitized FSP (functional service providers) contract research organizations (CROs).
For years, the playbook for managing these types of CRO economics was familiar. Sponsors negotiated rates while CROs managed headcount and utilization around those rates .
That playbook still holds true today in theory. However, the conditions underneath it have shifted enough that it no longer produces the results it used to. Funding is tighter, sponsors are smaller and more price-sensitive, timelines are compressing ahead of the patent cliff, and AI has moved from an experiment on the roadmap to a baseline expectation in every RFP.
None of that is unique to any one segment of the market, but these pressures land differently for FSO and unitized FSP providers than they do for full-service CROs. That’s because these businesses are built on rate cards for CRAs, monitors, and other functional resources. When sponsors squeeze rates or expect more output per unit, there's no broader program fee to absorb the hit, here the unit economics are the business.

